Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
412.2 DKK | +5.88% | +5.80% | +11.08% |
05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 | |
05-03 | Novonesis Provides Sales Guidance for the Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.08% | 27.66B | |
-6.69% | 4.12B | |
+11.55% | 1.76B | |
-18.40% | 583M | |
-17.62% | 429M | |
-81.65% | 216M | |
-13.81% | 111M | |
-17.03% | 50.49M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes, LinusBio Partner To Launch Lead Exposure Study In Mexico